The Asia Pacific Cellular Health Screening Market would witness market growth of 9.7% CAGR during the forecast period (2022-2028).
The use of cellular health screening is growing in personalized medicine. Numerous studies have demonstrated a relationship between telomere length and malignancies. In cancer that has advanced more severely, telomere shortening as a tumor suppressor emerges to be a key impact. Telomere length is influenced by a variety of factors, including inflammations, infections, and stress. Inflammation, in particular, induces oxidative stress, which leads to telomere erosion.
According to studies, telomere maintenance has a substantial impact on how environmental, behavioral, and genetic variables influence aging and related illnesses. To comprehend biological aging and genetic diseases, it is necessary to grasp how quickly telomeres change. In addition, disorders connected to aging, such as cancer, cardiovascular diseases, and compromised immune systems, have been related to telomere length decrease.
The development of telomere testing kits has proved to be a significant innovation aiding in the early diagnosis of cancers. A growing insistence on healthy life expectancy and an increment in the public's average age, accompanied by a rise in the acceptance of digital testing technologies has resulted in healthcare facilities to opt testing methods that are quick and accurate. Also, the likelihood of spotting a condition may increase if multiple tests respond to a single medical issue.
In the above middle Asia-Pacific nations and territories, lung, trachea, and bronchus cancer were the most common cancer types in 2016. In lower-middle and lower-income Asia-Pacific nations and territories, liver cancer was the leading cause of cancer fatalities in 2016. Stomach, colorectal, and breast cancer were other leading causes of cancer-related mortality. These deaths were associated with Helicobacter pylori infection and were more common in Mongolia, China, the Republic of Korea, Japan, and Vietnam. Deaths from colorectal cancer were greater in Australia, New Zealand, and Brunei Darussalam.
The China market dominated the Asia Pacific Cellular Health Screening Market by Country in 2021; thereby, achieving a market value of $354.8 million by 2028. The Japan market would showcase a CAGR of 8.9% during (2022 - 2028). Additionally, The India market is estimated to grow a CAGR of 10.4% during (2022 - 2028).
Based on Sample Type, the market is segmented into Blood, Saliva, Serum, and Urine. Based on Collection Site, the market is segmented into Hospital, Diagnostic Labs, Home, and Office. Based on Test Type, the market is segmented into Single Test Panels and Multi-test Panels. Based on Single Test Panels Type, the market is segmented into Oxidative Stress Tests, Inflammation Tests, Telomere Tests, and Heavy Metals Tests. The report also covers geographical segmentation of Cellular Health Screening market. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Cellular Health Screening Market is Projected to reach USD 4.3 Billion by 2028, at a CAGR of 9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics Incorporated, OPKO Health, Inc., Laboratory Corporation of America Holdings, Genova Diagnostics, Telomere Diagnostics, Inc., Life Length, S.L., Repeat Diagnostics, Inc., SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.), Cell Science Systems Corp. and Segterra, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Sample Type
By Collection Site
- Hospital
- Diagnostic Labs
- Home
- Office
By Test Type
- Single Test Panels
- Oxidative Stress Tests
- Inflammation Tests
- Telomere Tests
- Heavy Metals Tests
- Multi-test Panels
By Country
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
Companies Profiled
- Quest Diagnostics Incorporated
- OPKO Health, Inc.
- Laboratory Corporation of America Holdings
- Genova Diagnostics
- Telomere Diagnostics, Inc.
- Life Length, S.L.
- Repeat Diagnostics, Inc.
- SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
- Cell Science Systems Corp.
- Segterra, Inc.
TABLE 1 Asia Pacific Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Blood Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Blood Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Saliva Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Saliva Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Serum Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Serum Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Urine Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Urine Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Diagnostic Labs Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Diagnostic Labs Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Home Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Home Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Office Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Office Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Single Test Panels Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Single Test Panels Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Oxidative Stress Tests Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Oxidative Stress Tests Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific Inflammation Tests Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific Inflammation Tests Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Telomere Tests Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Telomere Tests Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Heavy Metals Tests Market by Country, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Heavy Metals Tests Market by Country, 2022 - 2028, USD Million
TABLE 37 Asia Pacific Multi-test Panels Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific Multi-test Panels Market by Country, 2022 - 2028, USD Million
TABLE 39 Asia Pacific Cellular Health Screening Market by Country, 2018 - 2021, USD Million
TABLE 40 Asia Pacific Cellular Health Screening Market by Country, 2022 - 2028, USD Million
TABLE 41 China Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 42 China Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 43 China Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 44 China Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 45 China Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 46 China Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 47 China Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 48 China Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 49 China Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 50 China Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 51 Japan Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 52 Japan Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 53 Japan Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 54 Japan Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 55 Japan Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 56 Japan Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 57 Japan Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 58 Japan Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 59 Japan Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 60 Japan Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 61 India Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 62 India Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 63 India Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 64 India Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 65 India Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 66 India Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 67 India Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 68 India Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 69 India Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 70 India Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 71 Australia Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 72 Australia Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 73 Australia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 74 Australia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 75 Australia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 76 Australia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 77 Australia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 78 Australia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 79 Australia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 80 Australia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 81 South Korea Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 82 South Korea Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 83 South Korea Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 84 South Korea Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 85 South Korea Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 86 South Korea Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 87 South Korea Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 88 South Korea Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 89 South Korea Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 90 South Korea Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 91 Malaysia Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 92 Malaysia Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 93 Malaysia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 94 Malaysia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 95 Malaysia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 96 Malaysia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 97 Malaysia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 98 Malaysia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 99 Malaysia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 100 Malaysia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 101 Rest of Asia Pacific Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 102 Rest of Asia Pacific Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 103 Rest of Asia Pacific Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 104 Rest of Asia Pacific Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 105 Rest of Asia Pacific Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 106 Rest of Asia Pacific Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 107 Rest of Asia Pacific Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 108 Rest of Asia Pacific Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 109 Rest of Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 110 Rest of Asia Pacific Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 111 Key information – Quest Diagnostics Incorporated
TABLE 112 Key Information – OPKO Health, Inc.
TABLE 113 Key Information – Laboratory Corporation of America holdings
TABLE 114 Key Information – Genova Diagnostics
TABLE 115 Key Information – Telomere Diagnostics, Inc.
TABLE 116 Key Information – LIFE LENGTH, S.L.
TABLE 117 Key Information – Repeat Diagnostics, Inc.
TABLE 118 Key Information – SpectraCell Laboratories, Inc.
TABLE 119 Key Information – Cell Science Systems Corp.
TABLE 120 Key Information – SEGTERRA (INSIDETRACKER)
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Quest Diagnostics Incorporated